TONIX PHARMACEUTICALS HLDG C's ticker is and the CUSIP is 890260706. A total of 88 filers reported holding TONIX PHARMACEUTICALS HLDG C in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $3,000 | -40.0% | 14,500 | 0.0% | 0.00% | – |
Q4 2021 | $5,000 | -44.4% | 14,500 | 0.0% | 0.00% | – |
Q3 2021 | $9,000 | -96.2% | 14,500 | -93.2% | 0.00% | -100.0% |
Q2 2021 | $238,000 | -29.8% | 214,500 | -18.9% | 0.00% | -33.3% |
Q1 2021 | $339,000 | +89.4% | 264,500 | 0.0% | 0.01% | +50.0% |
Q4 2020 | $179,000 | -19.4% | 264,500 | 0.0% | 0.00% | -20.0% |
Q3 2020 | $222,000 | +37.9% | 264,500 | 0.0% | 0.01% | +66.7% |
Q2 2020 | $161,000 | – | 264,500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Virtu Financial LLC | 734,477 | $441,000 | 0.04% |
GSA CAPITAL PARTNERS LLP | 516,218 | $310,000 | 0.03% |
Game Plan Financial Advisors, LLC | 27,216 | $16,000 | 0.01% |
MONECO Advisors, LLC | 35,000 | $21,000 | 0.01% |
Purus Wealth Management, LLC | 15,000 | $9,000 | 0.01% |
Renaissance Technologies | 6,038,664 | $3,630,000 | 0.01% |
Qube Research & Technologies Ltd | 540,878 | $325,000 | 0.00% |
D. E. Shaw & Co., Inc. | 6,690,867 | $4,022,000 | 0.00% |
Cutter & CO Brokerage, Inc. | 19,000 | $11,000 | 0.00% |
Van Hulzen Asset Management, LLC | 18,200 | $11,000 | 0.00% |